Home » Newsletters » BioWorld Science

BioWorld Science

July 3, 2007

View Archived Issues

REVA Medical enrolls first patients in CAD study of bioresorbable stent

FDA approves YM BioSciences' IND for AeroLEF for severe pain

Advancis Pharmaceutical changes name to MiddleBrook Pharmaceuticals

Critical Therapeutics and Dey sign copromotion agreement for Perforomist

NicOx begins third pivotal phase III trail for osteoarthritis of the hip

Preliminary results of SBG for neuroblastoma indicate good safety profile

Preliminary results from two phase II trials of Xcytrin for lung cancer

CombinatoRx discontinues CRx-150 program for rheumatoid arthritis

Final ferumoxytol phase III results expected in summer

Gene Logic to discover new development paths for Lundbeck drug candidates

NovaDel Pharma focuses on programs nearing NDA submission

SkyePharma licenses SKP-1041 to Somnus Therapeutics

Encouraging interim blinded data from phase III SinuNase study

Treanda NDA filing planned for Q3

Promising data from arimoclomol open-label extension trial in ALS reported

Isotechnika completes enrollment for ISA-247 phase IIb kidney transplant trial

E1-I.N.T. yields sustained reductions in HbA1c levels in type 2 diabetes patients

Phase I study supports further clinical evaluation of eltrombopag

Administration of a 11beta-HSD1 inhibitor in the evening improves metabolic parameters in DIO mice

Diabetes snapshots: dipeptidyl peptidase IV inhibitors

Lipid-lowering and antidiabetic activity of DRL-17564, a novel selective PPARgamma modulator

New data on SGLT2 inhibitors sergliflozin, dapagliflozin available

Liraglutide effective in lowering HbA1c in Japanese type 2 diabetes patients

CTA-018 reduces blood levels of parathyroid hormone in phase I trial

Intercell and Novartis sign vaccine development partnership

Interim results for phase I study of ALX-0081

Novel agents for HIV infection reported in recent ViroChem, Pfizer and CNRS patents

New agents targeting hepatitis C described in recent patents

Novel analgesic agents imparted in recent patent literature

Sciele Pharma files sNDA to the FDA for new Sular formulation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...